drugset

drugset / Trial / NCT03404856

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

NCT03404856 ↗

Phase 1/2 Unknown 5 enrolled Orpha Labs

NaSingle-groupOpen-labelTreatment

Summary

Study of ORL-1G in Patients With Glycogen Storage Disease Type 14

Timeline

Start: 2017-10-31
Primary completion: 2019-10-31
Completion: 2019-10-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ORL-1G	Unknown	—	Oral

Indications